Cargando…
CB1 Antagonism Exerts Specific Molecular Effects on Visceral and Subcutaneous Fat and Reverses Liver Steatosis in Diet-Induced Obese Mice
OBJECTIVE: The beneficial effects of the inactivation of endocannabinoid system (ECS) by administration of antagonists of the cannabinoid receptor (CB) 1 on several pathological features associated with obesity is well demonstrated, but the relative contribution of central versus peripheral mechanis...
Autores principales: | Jourdan, Tony, Djaouti, Louiza, Demizieux, Laurent, Gresti, Joseph, Vergès, Bruno, Degrace, Pascal |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844840/ https://www.ncbi.nlm.nih.gov/pubmed/20110567 http://dx.doi.org/10.2337/db09-1482 |
Ejemplares similares
-
Therapeutic potential of a novel peripherally restricted CB1R inverse agonist on the progression of diabetic nephropathy
por: Jacquot, Laetitia, et al.
Publicado: (2023) -
Orosensory Detection of Dietary Fatty Acids Is Altered in CB(1)R(−/−) Mice
por: Brissard, Léa, et al.
Publicado: (2018) -
Endocannabinoids Produced by White Adipose Tissue Modulate Lipolysis in Lean but Not in Obese Rodent and Human
por: Buch, Chloé, et al.
Publicado: (2021) -
Visceral and subcutaneous fat
por: Lederman, Henrique Manoel
Publicado: (2014) -
Chemical Synthesis, Pharmacokinetic Properties and Biological Effects of JM-00266, a Putative Non-Brain Penetrant Cannabinoid Receptor 1 Inverse Agonist
por: Muller, Tania, et al.
Publicado: (2022)